All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Endogenous hydrogen sulphide (H~2~S) is associated with microvascular tone regulation at 24h postnatal age in the preterm infant and production appears to be affected by both gestational age and sex \[[@pone.0121621.ref001]\]. Nitric oxide (NO) and carbon monoxide (CO) also play a crucial role in the transitional circulation of preterm neonates \[[@pone.0121621.ref002],[@pone.0121621.ref003]\]. NO is proposed to play a central role in the maintenance of vascular homeostasis in the perinatal period, however urinary excretion of NO metabolites do not correlate with early changes in microvascular blood flow in the preterm neonate \[[@pone.0121621.ref004]\]. It has been hypothesised that the rate of NO production in the endothelium of peripheral microvessels (via endothelial nitric oxide synthase (eNOS)) is lower than would be required to activate the downstream sGC pathway in vascular smooth muscle cells responsible for the excessive vasodilatation seen in premature neonates. This has led to the speculation that other mechanisms may be involved in both the production of NO in the microvasculature and its vasoactive effects on vascular smooth muscle cells during the transition from fetal to neonatal circulatory systems, with NO contributing to the maintenance of background tone throughout this period \[[@pone.0121621.ref005],[@pone.0121621.ref006]\]. CO levels, on the other hand, correlate with both gestational age and microvascular blood flow at 24h postnatal age, suggesting that CO production by very preterm neonates may contribute to their increased risk of microvascular dysfunction and physiological instability \[[@pone.0121621.ref004]\].

The interaction of these gasotransmitters may account for a large proportion of their action. For example, NO and CO interact in the neonatal cerebral vasculature to regulate vascular tone---acute elevation in CO produces vasodilatation, yet prolonged production inhibits NO production, causing cerebrovascular constriction. Knecht et al. \[[@pone.0121621.ref007]\], hypothesised this interaction between CO and NO may form the basis of a negative feedback system in the control of cerebrovascular tone. However, the interaction between NO and CO, and between these two systems and H~2~S may not be as simple as this. A number of studies examining the relationship between the gasotransmitters have been published, with conflicting results. The different findings reported by these various studies may be due to differences in the tissues studied, the animal studied and/or their developmental stage and the methods used \[[@pone.0121621.ref008],[@pone.0121621.ref009],[@pone.0121621.ref010]\]. Some of these findings are summarised in [Table 1](#pone.0121621.t001){ref-type="table"}. Whilst this is not an exhaustive list of all studies examining the interactions between the gasotransmitters, it gives some idea of the wide-ranging results observed in a number of discrete studies.

10.1371/journal.pone.0121621.t001

###### Published Interactions of the Gasotransmitters.

![](pone.0121621.t001){#pone.0121621.t001g}

  ****Effector****      ****Interaction****                                         ****Tissue****                                                     ****Species****   ****Developmental Stage****   ****Reference(s)****
  --------------------- ----------------------------------------------------------- ------------------------------------------------------------------ ----------------- ----------------------------- --------------------------------------------------------------------------
  *Nitric Oxide*                                                                                                                                                                                       
                        ↑ HO-1 expression (protein)                                 Aortic endothelial cells                                           Bovine                                          \[[@pone.0121621.ref011]\]
                        ↑ CO production and action                                  Cerebral vessels (pial arterioles)                                 Pig               Neonatal                      \[[@pone.0121621.ref012],[@pone.0121621.ref013],[@pone.0121621.ref014]\]
                        ↑ CO action (permissive enabler)                            Retina                                                             Salamander                                      \[[@pone.0121621.ref015]\]
                        ↑ CO, ↑ HO-1 expression (protein, mRNA)                     Aortic smooth muscle cells                                         Rat                                             \[[@pone.0121621.ref016]\]
                        ↑ CO, ↑ HO-1 expression                                     Mesangial cells                                                    Rat                                             \[[@pone.0121621.ref017]\]
                        ↑ CO, ↑ HO-1 expression                                     Fibroblasts (from lung)                                            Human             Embryonic                     \[[@pone.0121621.ref018]\]
                        ↑ CO, ↑ HO-1 expression                                     Kidney epithelial cells (cell line: LLC-PKI)                       Pig               Juvenile (male)               \[[@pone.0121621.ref019]\]
                        ↑ CO, ↑ HO-1 expression                                     Macrophages (cell line: RAW264.7)^1^                               Mouse                                           \[[@pone.0121621.ref020]\]
                        ↓ CO (via HO-1 inhibition)                                  Purified proteins                                                  Human                                           \[[@pone.0121621.ref021]\]
                        ↓ HO activity                                               Aortic endothelial cells (cell line: AG08472)                      Pig                                             \[[@pone.0121621.ref022]\]
                        ↓ HO-2 activity                                             Purified proteins                                                  Rat                                             \[[@pone.0121621.ref023]\]
                        ↑ CSE expression                                            Peritoneal macrophages                                             Mouse             Adult (male)                  \[[@pone.0121621.ref024]\]
                        ↑ H~2~S, ↑ CSE expression                                   Aorta                                                              Rat               Adult (male)                  \[[@pone.0121621.ref025]\]
                        ↓ CBS activity                                              Purified Proteins                                                  Human                                           \[[@pone.0121621.ref026],[@pone.0121621.ref027]\]
  *Carbon Monoxide*                                                                                                                                                                                    
                        ↑ NO release                                                Pulmonary artery endothelial cells                                 Bovine                                          \[[@pone.0121621.ref028]\]
                        ↑ NO release (at low concentrations of CO)                  Renal arteries                                                     Rat               Adult (male)                  \[[@pone.0121621.ref029]\]
                        ↓ NO, ↓ eNOS (at high concentrations of CO)                 Renal arteries                                                     Rat               Adult (male)                  \[[@pone.0121621.ref029]\]
                        ↓ NO (via NOS inhibition) after prolonged elevation of CO   Cerebral vessels (pial arterioles)                                 Pig               Neonatal                      \[[@pone.0121621.ref007]\]
                        ↓ NO (via NOS inhibition)                                   HO-1, HO-2 constructs                                              Rat                                             \[[@pone.0121621.ref023]\]
                        ↓ NOS                                                       Cerebellum (granule cells)                                         Rat               Neonate                       \[[@pone.0121621.ref030]\]
                        ↓ iNOS activity, ↓ nNOS activity                            Macrophages (iNOS), cerebellum (nNOS)                              Rat                                             \[[@pone.0121621.ref031]\]
                        ↓ iNOS expression (transcriptional level)                   Astrocytes                                                         Human             Fetal                         \[[@pone.0121621.ref032]\]
                        ↓ nNOS activity                                             Cerebellum (granule cells)                                         Rat               Neonatal                      \[[@pone.0121621.ref033]\]
                        ↓ H~2~S (via CBS inhibition)                                Astrocytes                                                         Mouse             Neonatal                      \[[@pone.0121621.ref034]\]
                        ↓ H~2~S, ↓ CSE expression                                   Aortic smooth muscle cells                                         Rat               Juvenile (male)               \[[@pone.0121621.ref035]\]
                        ↓ H~2~S (via CSE inhibition)                                Carotid body                                                       Mouse, rat        Adult (male)                  \[[@pone.0121621.ref036]\]
  *Hydrogen Sulphide*                                                                                                                                                                                  
                        ↑ NO release                                                Brain homogenates                                                  Rat                                             \[[@pone.0121621.ref037]\]
                        ↑ NO action (permissive enabler)                            Ileum, aorta                                                       Guinea Pig, Rat   Juvenile                      \[[@pone.0121621.ref038],[@pone.0121621.ref039]\]
                        ↓ NO effect                                                 Aorta                                                              Rat                                             \[[@pone.0121621.ref040]\]
                        ↓ NO                                                        Retina                                                             Salamander                                      \[[@pone.0121621.ref015]\]
                        ↓ NO activity                                               Aorta                                                              Rat               Adult (male)                  \[[@pone.0121621.ref041]\]
                        ↓ NO, ↓ iNOS                                                Macrophages (cell line: RAW264.7; lipopolysaccharide exposed)^1^   Mouse                                           \[[@pone.0121621.ref042]\]
                        ↓ eNOS                                                      Aorta                                                              Mouse, rat        Juvenile (male)               \[[@pone.0121621.ref043]\]
                        ↓ eNOS, ↓ nNOS, ↓ iNOS                                      Recombinant proteins                                                                                               \[[@pone.0121621.ref044]\]
                        ↑ CO, ↑ HO-1 expression (protein, mRNA)                     Pulmonary arteries (with induced hypoxic pulmonary hypertension)   Rat               Juvenile (male)               \[[@pone.0121621.ref045]\]
                        ↓ CO, ↓ HO-1 expression (protein)                           Aortic smooth muscle cells                                         Rat               Juvenile (male)               \[[@pone.0121621.ref035]\]

HO heme oxygenase; CSE cystathionine-γ-lyase; CBS cystathionine-β-synthase; NOS nitric oxide synthase (eNOS endothelial isoform, iNOS inducible isoform, nNOS neuronal isoform). ^1^leukaemic monocyte macrophage cell line.

The synergistic effect of the interactions between these gasotransmitters arises from their different signalling cascades and their ability to enhance or diminish the effects of one or more of the others. The aim of the present study was to establish theoretical models of the interactions of the gasotransmitters and their combined effects on blood flow in the preterm newborn. This would provide a framework for establishing and testing current and future mechanistic hypotheses in this population. In order to achieve this, we measured the levels of all three gasotransmitters in the one neonatal population and characterised the interrelationships between NO, CO and H~2~S using structural equation modelling. As the differences in CO and H~2~S independently only account for a proportion of the vascular dysfunction observed in preterm neonates at 24h postnatal age we hypothesised that the interactions of NO, CO and H~2~S would account for a greater proportion of the microvascular tone dysregulation observed in the preterm newborn than the investigation of each of these molecules in isolation.

Methods {#sec006}
=======

Subjects {#sec007}
--------

Neonates 24--36 weeks' gestation (n = 96) were studied at 24h postnatal age as part of the Cardiovascular Adaptation of the Newborn Study 2 (CANS2). These neonates form part of the cohort reported on previously \[[@pone.0121621.ref001],[@pone.0121621.ref046]\]. Hypoxic ischemic encephalopathy, congenital malformations, chromosomal disorders or known congenital infection excluded admission to this study. The study protocol was approved by the human ethics committees at John Hunter Hospital and the University of Newcastle. Parental informed, written consent was obtained prior to investigation.

Microvascular studies {#sec008}
---------------------

Investigations were performed at 24h postnatal age with a Periflux 5001 laser Doppler (Perimed AB, Jarfalla, Sweden) with a temperature-regulated probe (Probe 457, Perimed) set at 36°C sited on the lateral aspect of the neonates' lower limb as previously described \[[@pone.0121621.ref046]\].

Clinical Illness severity {#sec009}
-------------------------

Clinical illness severity was evaluated using the Clinical Risk Index for Babies (CRIB) II scoring system \[[@pone.0121621.ref047]\].

Carbon monoxide measurement {#sec010}
---------------------------

CO binds competitively to haemoglobin, in preference to oxygen, to form carboxyhaemoglobin (COHb), which represents an in vivo sink for CO. Arterial COHb levels were determined at 24h postnatal age through spectrophotometry by using an ABL700 blood gas analyzer (Radiometer, Copenhagen, Denmark) and expressed as a proportion of total haemoglobin concentration as previously described \[[@pone.0121621.ref004]\].

Urine collection {#sec011}
----------------

24-hour urine samples were collected on day 2 of postnatal life as previously described \[[@pone.0121621.ref048]\]. Exact 24-hour urinary output was calculated by weighing diapers before and after use. As humidity can contribute to diaper weight, the degree and length of time in humidity were recorded and adjustments were made to calculate "true" increase as previously described \[[@pone.0121621.ref049]\].

Nitrate/nitrite measurement {#sec012}
---------------------------

NO has a short physiological half-life, making it difficult to measure directly. In order to assess total body turnover of NO, the more stable end products of NO oxidation, nitrate and nitrite, were measured in urine using a commercially available colorimetric assay according to manufacturer's instructions (Cayman Chemical Company, Ann Arbor, USA). Nitrate/nitrite levels were adjusted for 24h output and body weight to give a measure of total body output/24h (nmol/24h/kg).

Thiosulphate measurement {#sec013}
------------------------

Thiosulphate, a stable urinary metabolite of H~2~S was used to assess total body turnover of H~2~S, due to the short half-life and volatile nature of the gas. Thiosulphate was measured by reversed-phase liquid chromatography as previously described \[[@pone.0121621.ref001],[@pone.0121621.ref050]\]. Thiosulphate levels were adjusted for 24h output and body weight to give a measure of total body output/24h (nmol/24h/kg).

Statistical methods {#sec014}
-------------------

Stata 13 for MacOSX (StataCorp LP, Texas, USA) was used for statistical analyses and structural equation modelling. Stata 13 and Prism 6 for MacOSX (GraphPad Software Inc., La Jolla, CA) were used for generation of figures. Data are presented as median (range) or mean and SEM where appropriate. Differences between groups were analysed by Mann-Whitney U-test unless otherwise stated. The relationships between levels of CO, NO, H~2~S and microvascular blood flow were assessed through partial correlation controlling for the influence of gestational age as in our previous studies \[[@pone.0121621.ref001],[@pone.0121621.ref004]\]. Structural equation modelling was then performed in order to examine the combination of these effects on microvascular blood flow.

Structural equation modelling allows the examination of complex causal hypotheses on a set of intercorrelated non-experimental data and can be used for both exploration and confirmation of theoretical models \[[@pone.0121621.ref051]\]. For an exploratory approach such as that presented in the current study, a detailed model specifying the relationships among variables is not made *a priori*. This approach is considered superior over other correlational methods such as regression as multiple variables are analysed simultaneously, and latent factors reduce measurement error. When used as an exploratory or confirmatory approach, structural equation modelling provides information about the complex nature of disease and health behaviours. This is achieved by the examination of both direct and indirect, and unidirectional and bidirectional relationships between measured and latent variables \[[@pone.0121621.ref052]\]. In our particular construct, this was the interaction between the three gasotransmitters and their individual and combined effects on microvascular blood flow. All possible models were manually constructed for our three input (NO, CO and H~2~S) and one output (microvascular blood flow) variables. These models were then tested and assessed for suitability by χ^2^ Goodness of Fit and root mean square error of approximation (RMSEA). Lower χ^2^ values represent a better predicted model, whilst an RMSEA of below 0.06 shows a good fit \[[@pone.0121621.ref053]\]. RMSEA also allows for the calculation of a confidence interval (CI) around the predictive value of the model \[[@pone.0121621.ref054]\].

Results {#sec015}
=======

Of the 96 preterm neonates in the cohort, 6 neonates did not have complete data and could not be included in the model. Physical and clinical characteristics, including microvascular blood flow measurements for the remaining 90 neonates included in the model are reported in [Table 2](#pone.0121621.t002){ref-type="table"}.

10.1371/journal.pone.0121621.t002

###### Physical Characteristics of Neonates.

![](pone.0121621.t002){#pone.0121621.t002g}

                                               Female (n = 43)     Male (n = 47)
  -------------------------------------------- ------------------- --------------------
  Gestational Age (weeks)                      28 (24--35)         29 (24--35)
  Birth Weight (kg)                            1.06 (0.45--2.38)   1.27 (0.56--2.76)
  Microvascular Blood Flow (PU)                43.4 (4.7--266.8)   40.4 (6.5--216.64)
  Completed Antenatal Glucocorticoids (n, %)   31 (72%)            36 (77%)
  APGAR score at 5 min                         8 (4--10)           9 (4--10)
  Clinical Risk Index for Babies II score      8 (0--15)           5 (0--16)
  Mean Blood Pressure at 24h                   37.5 (24--68)       38 (26--81)
  Small for Gestational Age                    1 (2%)              6 (13%)
  Significant patent ductus arteriosus         11 (26%)            12 (26%)
  Intraventricular haemorrhage, grade ≥2       2 (5%)              3 (6%)
  Sepsis                                       11 (26%)            13 (28%)
  Died                                         4 (9%)              4 (9%)

Data presented as median (range) or number (percentage) as appropriate. PU laser Doppler perfusion units

Consistent with our previously reported observations in this cohort of neonates, which included the 96 preterm neonates (as well as 42 term neonates)) \[[@pone.0121621.ref046]\], microvascular blood flow at 24h postnatal age correlated with gestational age in this subset of neonates (all neonates p\<0.0001, *r* = -0.54; females p = 0.009, *r* = -0.41; males p\<0.0001, *r* = -0.64). There was no effect of birth weight on baseline microvascular blood flow when gestational age was accounted for (all neonates p = 0.82, *r* = -0.03; females p = 0.36, *r* = -0.15; males p = 0.66, *r* = 0.07). Detailed microvascular blood flow data for this cohort of neonates has been previously published \[[@pone.0121621.ref046]\].

Gasotransmitter measurement {#sec016}
---------------------------

NO levels were higher in females than males (females 21.4(4.6--37.1)nmol/24h/kg vs males 20.1(0.9--56.7)nmol/24h/kg, p = 0.058). No differences in CO levels between sexes were observed (females 1.5(0.9--4.1)% vs. males 1.4(0.9--2.2)%, p = 0.29). Thiosulphate levels have been previously reported for this cohort \[[@pone.0121621.ref001]\].

Interactions of the Gasotransmitters and their relationship with microvascular blood flow {#sec017}
-----------------------------------------------------------------------------------------

Gestational age at birth was related to total gasotransmitter levels: gestational age was inversely correlated with NO (p = 0.03, *r* = -0.24), with no differences observed between males and females. Gestational age was also inversely correlated with CO (p = 0.0003, *r* = -0.45) and H~2~S (p = 0.02, *r* = -0.25). As urinary nitrates and thiosulphate are standardised to body weight, we could not examine the relationship between birth weight and NO and H~2~S. For CO, there was no effect of birth weight when gestational age was accounted for (all neonates p = 0.21, *r* = -0.17; females p = 0.14, *r* = -0.17; males p = 0.42, *r* = -0.15).

As gestational age is strongly related to the level of gasotransmitters, the relationships between levels of CO, NO, H~2~S and microvascular blood flow were assessed through partial correlation, controlling for the influence of gestational age. We observed a significant positive relationship between NO levels and microvascular blood flow for males but not females (p = 0.03, *r* = 0.38; females p = 0.91, *r* = -0.02). Furthermore, there was a significant positive relationship between CO levels and microvascular blood flow for males but not females (males p = 0.03, *r* = 0.38; females p = 0.88, *r* = -0.03) and H~2~S and flow (males p = 0.05, *r* = 0.29; females p = 0.72, *r* = 0.06).

Again, using partial correlations in order to account for differences associated with gestational age, we found no relationship between NO and CO (p = 0.18, *r* = 0.18); however, we observe a positive relationship between NO and H~2~S (p = 0.008, *r* = 0.28) and an inverse correlation between CO and H~2~S (p = 0.01, *r* = -0.33).

Structural equation modelling {#sec018}
-----------------------------

Based on the results of the present study, several theoretical models were computed ([S1 Data](#pone.0121621.s001){ref-type="supplementary-material"}). The overall model with the best fit (χ^2^ = 1.02; RMSEA = 0.017(CI 0.00--0.28)) is presented in [Fig. 1](#pone.0121621.g001){ref-type="fig"}. This model had a better Goodness of Fit in females (χ^2^ = 0.03; RMSEA\<0.0001(CI 0.00--0.21)) than males (χ^2^ = 1.88; RMSEA = 0.137(CI 0.00--0.44)). In this model, NO promotes H~2~S production (overall p = 0.002, z = 3.05; males p = 0.06, z = 1.88; females p\<0.0001, z = 4.53), whilst CO inhibits H~2~S (overall p = 0.18, z = -1.34; males p = 0.84, z = -0.20; females p\<0.0001, z = -5.39). As described above, NO levels were higher in females than males and no differences in CO levels between sexes were observed. The net result was a slightly enhanced positive relationship of all vasodilators acting on the microvasculature in males (p = 0.006, z = 2.74) compared to the effect of H~2~S on microvascular blood flow in isolation (model constructed without inclusion of other gasotransmitters; p = 0.008, z = 2.67). In females, the model predicted a lower contribution of H~2~S on microvascular blood flow (p = 0.905, z = -0.12) compared to the effect of H~2~S in isolation (p = 0.753, z = 0.31). The model predicted covariance in the levels of NO and CO despite a lack of any direct effect of one on the other (p = 0.362, z = 0.91), this may reflect an effect of gestational age. CO had no direct effect on microvascular blood flow in the model presented, however inclusion of this pathway improved goodness of fit compared to the same model minus this interaction (overall with CO effect χ^2^ = 1.02 vs without χ^2^ = 2.34, females with CO effect χ^2^ = 0.03 vs without χ^2^ = 0.29, males with CO effect χ^2^ = 1.88 vs without χ^2^ = 2.67). Additionally, the inclusion of a direct effect of CO on microvascular blood flow increased the effect of H~2~S on blood flow in the overall model (with CO effect p = 0.012, z = 2.52 vs. without p = 0.019, z = 2.34) and in males (with CO effect p = 0.006, z = 2.74 vs. without p = 0.008, z = 2.67).

![Structural equation model of predicted interactions of the gasotransmitters and their contribution to the regulation of microvascular blood flow at 24h postnatal age in the preterm human.\
The overall model (males and females combined) is presented and has a Goodness of Fit of χ^2^ = 1.02 and RMSEA value of 0.017 (CI 0.00--0.28). Structural equation modelling examines linear causal relationships among variables, while simultaneously accounting for measurement error. The measurement error, or variance, determined in the model is 0.66 for microvascular blood flow, 0.77 for hydrogen sulphide, 0.24 for nitric oxide and 0.07 for carbon monoxide. NO was positively correlated with H~2~S (p = 0.002, z = 3.05). There was an inverse correlation between CO and H~2~S (p = 0.18, z = -1.34). There was a significant relationship between H~2~S and microvascular blood flow (p = 0.012, z = 2.52) when the input of NO and CO to H~2~S was included in the model.](pone.0121621.g001){#pone.0121621.g001}

Alternate models were tested and are presented in [S1 Data](#pone.0121621.s001){ref-type="supplementary-material"}. None of these models had a more acceptable χ^2^ or RMSEA value and CI, thus the selection of the model presented in [Fig. 1](#pone.0121621.g001){ref-type="fig"}.

Discussion {#sec019}
==========

Structural equation modelling is sometimes referred to as "causal modelling". However, a number of recent publications highlight that caution must be taken when interpreting the results as causation rather than association. Beran and Vialato \[[@pone.0121621.ref052]\] proposed that for causation to be determined via structural equation modelling the following criteria must be met: 1) there must be an empirical association between the variables, i.e. they are significantly correlated; 2) a common cause of the two variables must have been ruled out; 3) the two variables have a theoretical connection; and 4) that one variable precedes the other, and if the preceding variable changes, the outcome variable also changes (and not vice versa). These requirements are unlikely to be satisfied using non-experimental data, thus, causation cannot be definitively demonstrated. Rather, causal inferences that inform future experimental work may be drawn. The work presented here, and the final model proposed, in fact satisfies the majority of the criteria for causation as set out by Beran and Vialato.

Firstly, the gasotransmitters and microvascular blood flow are inter-correlated: as we have shown previously, CO \[[@pone.0121621.ref004]\] and H~2~S \[[@pone.0121621.ref001]\] were associated with higher microvascular blood flow in male preterm neonates. Contrary to our previous findings, we observed a significant, positive relationship between NO and microvascular blood flow in male preterm neonates. Furthermore, NO was positively correlated with H~2~S, whilst CO was inversely correlated with H~2~S. Thus, criteria 1 is met. Secondly, the variables have a theoretical connection (criteria 3): the gasotransmitters have known vasodilatory actions, and high microvascular blood flow in the neonate is assumed to relate to a loss of peripheral vascular tone. More specifically, a number of studies have now shown interactions between the three gasotransmitters ([Table 1](#pone.0121621.t001){ref-type="table"}). Finally, criteria 4 specifies that one variable precedes the other; in the studies presented here, the testing of alternate models (see [S1 Data](#pone.0121621.s001){ref-type="supplementary-material"}) suggests that changes in CO and NO precede changes in H~2~S, and not vice versa; however, experimental studies need to be performed in order to confirm this directionality, especially considering the volume of experimental data that supports an effect of H~2~S on NO ([Table 1](#pone.0121621.t001){ref-type="table"} and \[[@pone.0121621.ref055]\]), as well as an effect of NO on H~2~S.

Thus, we present here a theoretical model, supported by our human observational studies, for the regulation of microvascular tone in the preterm newborn by the action and interaction of the gasotransmitters, which provides a construct from which future experimental studies may work in order to understand the development of circulatory compromise in this vulnerable population.

Interactions of the Gasotransmitters and their relationship with microvascular blood flow {#sec020}
-----------------------------------------------------------------------------------------

We observed a significant positive relationship between NO and H~2~S. Previous studies have reported that NO inhibits H~2~S production via CBS \[[@pone.0121621.ref026],[@pone.0121621.ref027]\] but induces CSE expression, and consequently, H~2~S production via that pathway \[[@pone.0121621.ref025]\]. This may suggest that in the human preterm newborn, CSE expression is significantly modulated by NO. We have evidence from our animal model that increases in H~2~S associated with microvascular dysregulation are driven by CSE-dependent mechanisms \[[@pone.0121621.ref056]\]. The inhibition of CSE prevents the increased H~2~S production observed at 24h postnatal age in the preterm guinea pig pup, and CSE-dependent, but not CSE-independent H~2~S production is associated with increased microvascular blood flow. The relationship between NO and CSE/H~2~S needs to be investigated further, particularly as this appears to be associated with higher microvascular blood flow as measured by laser Doppler. Contrary to our previous findings \[[@pone.0121621.ref004]\], we observed a significant, positive relationship between NO and microvascular blood flow at 24h postnatal age in male neonates. One source of these differing results may be the use of different methodology---in our previous papers NO metabolites were standardised to creatinine to allow for comparisons between time points and subjects. It has been shown, however, that creatinine may not be the best molecule for this purpose in the neonate as levels change significantly in the transitional period \[[@pone.0121621.ref057],[@pone.0121621.ref058]\].

In females, a lower contribution of H~2~S to microvascular tone regulation was predicted when the other gasotransmitters were added into the model. This suggests that the effect of either NO, CO, or both, negates the effect of H~2~S to such a degree that there is no net effect on vascular tone. This may be primarily due to CO, which is inversely correlated with H~2~S and may reflect an inhibitory action of CO on H~2~S, in line with published reports that have demonstrated that CO decreases the production and action of H~2~S \[[@pone.0121621.ref034],[@pone.0121621.ref035],[@pone.0121621.ref036]\]. This is of particular interest in this cohort, as females and males had comparable levels of CO, suggesting some protective role of this molecule against inappropriate vasodilation in the female. The findings of our current study are discrepant with our previous studies, which showed that males had higher levels of CO and that this was associated with inappropriate peripheral microvascular dilatation and physiological instability in the first few days of life \[[@pone.0121621.ref004]\]. There are a number of possible explanations for these differences. Firstly, the infants in our original studies were younger (median age 1 week older in the present study, with neonates up to 35 weeks included compared to an upper age of 32 weeks in the previous study) and therefore, sicker, than the neonates in the present study. Secondly, there was a much higher rate of antenatal glucocorticoid exposure in the present study (74% in the current study compared to 59% in the previous study).

Limitations and future research {#sec021}
-------------------------------

The present study does not provide direct confirmation of the mechanisms of action, the expression of gasotransmitter-producing enzyme/s or feedback of the gaseous molecule on the producing and/or releasing pathways. Rather, the aim of this study was to establish a theoretical model of gasotransmitter interactions in the preterm newborn, and the potential effect of these interactions on microvascular blood flow. Given the evidence of interactions between the three gasotransmitters in the preterm newborn population presented here, we propose future mechanistic studies should not focus solely on one of these gasotransmitters as driving dysfunction, but rather investigate the interactions among CO, NO and H~2~S in this context.

It is not possible to experimentally test these interactions within the sick human preterm infant population studied here, however the results of the present study can be used to inform future studies in relevant animal models \[[@pone.0121621.ref059],[@pone.0121621.ref060],[@pone.0121621.ref061]\] in order to elucidate the mechanisms underlying these correlations.

Future research should also investigate the mechanisms that give rise to the different interactions and effects of the gasotransmitters in male versus female preterm neonates. As many of the steroid hormone receptors (such as those for progesterone, estrogen and testosterone) are located within the endothelium and smooth muscle layers of blood vessels, the sex hormones may have influence over these vasoactive substances and the downstream signalling mechanisms involved in microvascular dilatation in a sex-specific manner.

We hypothesised that rates of antenatal glucocorticoids may contribute to the differences in CO levels and effect on blood flow observed in the present study compared to our previous studies in a similar cohort \[[@pone.0121621.ref004]\]. Glucocorticoids, such as antenatally administered betamethasone can modulate blood pressure, vascular reactivity and the production and action of vasoconstrictors and vasodilators, such as the gasotransmitters \[[@pone.0121621.ref062],[@pone.0121621.ref063]\]. In mice, administration of glucocorticoids reduces eNOS levels (through decreased transcription and increased degradation) in aorta, liver and kidney \[[@pone.0121621.ref064],[@pone.0121621.ref065],[@pone.0121621.ref066],[@pone.0121621.ref067]\]. Dexamethasone is known to reduce the release of NO from the endothelium and completely suppresses the inducible form of NOS \[[@pone.0121621.ref068],[@pone.0121621.ref069],[@pone.0121621.ref070],[@pone.0121621.ref071]\]. Dexamethasone also downregulates HO-1 expression in models of systemic inflammation \[[@pone.0121621.ref072]\] and suppresses CSE expression, reducing H~2~S production, both directly through regulation of transcription and through inhibition of NO production, which is known to drive CSE expression \[[@pone.0121621.ref024]\]. Glucocorticoids are also known to decrease other vasodilators, including prostaglandins and enhance the effects of vasoconstrictors such as Angiotensin II \[[@pone.0121621.ref073],[@pone.0121621.ref074]\] and norepinephrine \[[@pone.0121621.ref063],[@pone.0121621.ref075],[@pone.0121621.ref076]\]. The effect of glucocorticoids on the levels of individual vasoactive molecules, and overall vascular tone regulation, needs to be studied further in order to determine if antenatal glucocorticoid exposure effects gasotransmitters production and/or action in the preterm newborn. This is particularly relevant in the context of sex differences in gasotransmitters-related regulation of vascular tone, as it is well characterised that males and females metabolise and respond to glucocorticoid exposure differently \[[@pone.0121621.ref048],[@pone.0121621.ref077]\].

Future studies should also consider the effect of a range of other vasoactive inputs, such as the sympathetic nervous system and the renin-angiotensin system and the newly identified fourth gasotransmitter, ammonium \[[@pone.0121621.ref078]\]. The action of these pathways and their interaction with the gasotransmitter system presented here may contribute to overall vascular tone regulation in this vulnerable population.

Conclusions {#sec022}
===========

We identified significant correlations between the gasotransmitters NO, CO and H~2~S and microvascular blood flow in preterm neonates. This allowed us to produce a theoretical model for the regulation of microvascular tone in the preterm newborn by the action and interaction of the gasotransmitters. The results of the present study suggest that CO may confer some protective advantage in the female preterm neonate whilst in the male neonate, H~2~S production may be aberrantly modulated by NO, likely through changes in CSE expression. This hypothesis is supported by the results of the present study, previous studies by others (see [Table 1](#pone.0121621.t001){ref-type="table"}) and those of ourselves---we have shown that CSE production is upregulated in the preterm newborn male and that H~2~S produced via CSE (but not CSE-independent pathways) correlates with microvascular tone dysregulation \[[@pone.0121621.ref056]\]. The relationship between NO and CSE/H~2~S is associated with higher microvascular blood flow and may be of particular interest given the wealth of literature surrounding an interaction between these two molecules (and their production pathways); further work is required in order to confirm this. We present a theoretical model built on observations within a human population which provides evidence of gasotransmitters interactions in the preterm newborn. This model provides a framework for establishing and testing current and future mechanistic hypotheses within this population.

Supporting Information {#sec023}
======================

###### Alternate Structural Equation Models.

Alternate models were tested and are presented here. As in the manuscript, the interaction between the three gasotransmitters and their individual and combined effects on microvascular blood flow were assessed. All models were manually constructed and presented here for our three input (NO, CO and H~2~S) and one output (microvascular blood flow) variables. These models were then tested and assessed for suitability by χ^2^ Goodness of Fit and root mean square error of approximation (RMSEA). Lower χ^2^ values represent a better predicted model, whilst an RMSEA of below 0.06 shows a good fit. RMSEA also allows for calculation of a confidence interval (CI) around the predictive power of the model. None of these models had a more acceptable χ^2^ or RMSEA value and CI, thus the selection of the model presented within the manuscript.

(PDF)

###### 

Click here for additional data file.
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